Adam K. Walker
University of Sydney
Adam K. Walker is listed at University of Sydney. Adam is scheduled to speak at AD/PD 2027 – Advances in Science & Therapy on 19 March 2027.
Compiled from published conference agendas; not yet confirmed by Adam. Is this you? Claim this profile.
About
Professor Adam Walker has over 20 years’ experience in neurodegenerative disease research, including PhD in Neuroscience from the University of Melbourne and postdoctoral training at the Centre for Neurodegenerative Disease Research, University of Pennsylvania. He is a Bill Guest FightMND Research Fellow, and Chair of Pharmacological Sciences in the Sydney Pharmacy School at The University of Sydney, where he leads the Neurodegeneration Pathobiology Laboratory at the Charles Perkins Centre. At The University of Sydney, he is also Convenor of the TDP-43 Research Cluster within the Centre for Drug Discovery Innovation, and Director of Academic Research in the Sydney Pharmacy School. Previously, he was a Group Leader in the Clem Jones Centre for Ageing Dementia Research at the Queensland Brain Institute, The University of Queensland (2018-2025), where he is now Honorary Professor. His research aims to define molecular mechanisms of ALS and FTD to define better therapeutic pathways for peo
Upcoming
AD/PD 2027 – Advances in Science & Therapy 16 March 2027 – 20 March 2027
- RETHINKING MODELS OF NEURODEGENERATION: FROM MECHANISMS TO HUMAN RELEVANCE Speaker · 19 March 2027
Spoke alongside
People who have shared a session with Adam at events on B2DB.
- Fabrizio Gardoni Full Professor · Dipartimento di Scienze Farmaceutiche – Università degli Studi di Milano 1 shared session
- MIchael Ugrumov Koltzov Institute of Developmental Biology of the Russian Academy of Sciences 1 shared session
- Sébastien S. Hébert Laval University 1 shared session